“showed a trend”

Suprathreshold stimulation of right PMd also showed a trend ( p = 0.066).

SOL was significantly higher in the IN compared to the GS group ( p = 0.004) and it showed a trend to a significant difference between the IN and PS as well ( p = 0.066).

Locoregional recurrence showed a trend toward reduction (3.8% [5/132] vs. 9.4% [31/330], p = 0.066), whereas distant metastasis and overall mortality were similar between groups. 3.4.

Age showed a trend-level effect - F(1,89) = 3.47, P = .066, η 2 G = 0.30, 95% CI, 0.00;1.00, and including age did not change the pattern of CAPS effects.

In multivariable analysis, BEND2 alterations showed a trend toward independent prognostic significance after adjustment for major clinical variables (hazard ratio [HR] = 2.9, 95% confidence interval [CI]: 0.9–8.9; p = 0.066) ( Figure 2 C).

Lung metastasis showed borderline significance (HR 1.34; p = 0.071), and the use of bevacizumab in second or later lines showed a trend toward reduced mortality (HR 0.70; p = 0.066).

Although the good‐quality embryo rate was not statistically significant in the two comparisons, it still showed a trend that the flexible GnRH‐ant group was higher than the PPOS group(69.6% vs. 65.9%, p = 0.066) (Table 2 ). 3.3.

Univariate analysis showed a trend toward higher recurrence rates in females ( p = 0.066), advanced pN stage ( p = 0.1) and in cases with perineural invasion ( p = 0.095), without reaching statistical significance (Table 4 ).

When comparing baseline values (Pre-T1) with measurements obtained at the end of the protocol (Post-T10), serum serotonin levels showed a trend toward statistical significance (t(13) = −2.006, p = 0.066), accompanied by a moderate effect size (Cohen’s dz = 0.536).

There was an interaction of season × age ( p = 0.002; Figure 2 a) whereby in summer, junior cats spent more time standing (13.8 ± 1.84%) than mature cats (8.6 ± 0.64%; p < 0.001) and showed a trend of standing more than prime cats (10.9 ± 0.80%; p = 0.066).

Dietary supplement use showed a trend across age groups ( p = 0.066) ( Table S3 ), with moderate sex differences observed (Cramér’s V = 0.26, p < 0.001) ( Table 1 ).

Furthermore, on day 13, the continuous incubation of 5 mg/mL postbiotics to the organoids challenged with afatinib showed a trend for better recovery of the epithelial barrier function compared with the challenged control (55 ± 7 Ω × cm 2 vs. 96 ± 11 Ω × cm 2 ; p = 0.066; Figure 4 A,D).

Patients with UICC stage IIIA were significantly more likely to die without documented progression ( p = 0.045) and showed a trend toward a lower incidence of BM as the first site of progression ( p = 0.066).

Female sex and full-time employment were associated with attenuated weight loss, and the number of concomitant psychotropic medications with moderate weight-gain risk showed a trend toward greater weight reduction ( p = 0.066).

The RAFT‐AF 276 trial is the largest RCT in recent years, and showed a trend towards reduced all‐cause mortality and HF hospitalization rates in the ablation therapy group compared with the medical therapy (rate control) group (P=0.066).

However, on exploratory analyses, the METTL3/ALKBH5 gene expression ratio was predictive of inferior OS (HR =1.052 p= 0.032) and showed a trend towards inferior EFS (HR =1.044 p = 0.066) ( Table 4 B).

Urban Roads On urban roads, the horizontal gaze median showed a trend toward a lower value at night ( Θ m e d _ d a y = 0.09 ° , Θ m e d _ n i g h t = − 0.22 ° , p = 0.0660).

In refractory IIH cases, while the liraglutide group showed a trend toward improvement at 3 months (RR 0.791, 95% CI 0.615–1.017, p = 0.066) and 24 months (RR 0.913, 95% CI 0.778–1.072, p = 0.267), these reductions also did not achieve statistical significance.

Our interaction analysis also showed a trend ( P = 0.066) suggesting arthralgia might modify the TNFi vs nbUVB treatment effect.

CTLA-4 distribution showed a trend of association with a shorter survival ( p = 0.066) although the difference was not statistically significant.

Patients with disease activity higher than the median at golimumab initiation showed a trend to lower retention (p=0.066).

For clearance, BMI showed a trend toward a negative association (β-coefficient = − 0.61, 95% CI −1.27 - 0.05, p = 0.066).

Solely physical activity-related laws showed a trend towards a decreasing effect on BMIz ( p = .066), suggesting that for every additional physical activity-related law, the average BMIz among children and adolescents would decrease by 0.005.

Interestingly, diabetes showed a trend toward reduced AAA risk (OR=0.386, 95% CI: 0.140–1.063, P=0.066).

pBD2 showed a trend of an increased IL-2 content compared with the control group ( p = 0.066) but had no significant impact on the levels of pro-inflammatory cytokines TNF-α and IL-6 ( p > 0.05).